12:00 AM
 | 
Jul 23, 2001
 |  BioCentury  |  Finance

Analyst picks & changes

Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Andover, U.K.

Business: Neurological, Infectious diseases

ABN-AMRO analyst Nick Woolf said SHP may experience generic...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >